ConductScience.org, home

Trial · NCT01639443

Reducing VA No-Shows: Evaluation of Predictive Overbooking Applied to Colonoscopy

NCT01639443, Not applicable, Completed, VA Office of Research and Development; results first posted 2016-10-31

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Reducing VA No-Shows: Evaluation of Predictive Overbooking Applied to Colonoscopy. Trials, record NCT01639443. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01639443

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Reducing VA No-Shows: Evaluation of Predictive Overbooking Applied to Colonoscopy
NCT number
NCT01639443
Status
Completed
Phases
Not applicable
Enrollment
180 participants, actual
Lead sponsor
VA Office of Research and Development
Conditions
Colon Cancer
Interventions
Predictive no-show overbooking
First posted
2012-07-12
Last updated
2018-04-12
Results first posted
2016-10-31
Limitations and caveats
This study was impeded by our ability to schedule Veterans into Fast-Tracked appointments. Although the method is very promising, integration of predictive scheduling is vital for this program to benefit Veterans on a large scale.

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPercentage of GI Clinic Capacity FilledAfter 12 months of running study in clinic
Investigators' primary objective will be to evaluate the impact of no-show predictive overbooking on percentage of the GI endoscopy clinic that are filled on a given day. Days where at least one Fast-tracked patient attended an appointment were compared to days where only Control patients attended appointments. Percentage of GI Clinic Capacity is calculated as the number of appointments completed divided by number of appointment spots available on a given day. This percentage was compared between Fast-tracked days and Control days, using data from 1672 patients.
SecondaryScheduling-to-procedure Lag TimeAfter 12 months of running study in clinicThe investigators will calculate the mean daily lag time for all colonoscopy and upper endoscopies performed per day
SecondaryDaily Service Denials ("Bumps")After 12 months of running study in clinicThe investigators will compare the number of patients bumped per day between scheduling approaches
SecondaryAdvanced Adenoma Detection/Cecal Intubation RatesAfter 20 months of running study in clinicThe investigators will compare daily advanced adenomatous polyp detection and daily cecal intubation rates between groups.
SecondaryLength of WorkdayAfter 12 months of running study in clinicLength of Workday in hours (comparing days with Fast-Tracked Appointments to Control days without)
SecondaryCost ComparisonsAfter 12 months of running study in clinicFor cost comparisons, the investigators will aggregate total provider overtime costs for colonoscopies performed. Cost is reported per day.

Outcomes6

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYPercentage of GI Clinic Capacity FilledAfter 12 months of running study in clinic
These 1672 patients are a subset of all patients who were enrolled in this study. We dropped data on a first wave of participants (69 Fast-tracked and 3294 Controls) because of problems incorporating recruitment strategy into clinic. However, data from these individuals was used to build predictive model.
percentage of clinic capacity filledMEAN
SECONDARYScheduling-to-procedure Lag TimeAfter 12 months of running study in clinic
These 1672 patients are a subset of all patients who were enrolled in this study. We dropped data on a first wave of participants (69 Fast-tracked and 3294 Controls) because of problems incorporating recruitment strategy into clinic. However, data from these individuals was used to build predictive model.
daysMEAN
SECONDARYDaily Service Denials (Bumps)After 12 months of running study in clinic
These 1672 patients are a subset of all patients who were enrolled in this study. We dropped data on a first wave of participants (69 Fast-tracked and 3294 Controls) because of problems incorporating recruitment strategy into clinic. However, data from these individuals was used to build predictive model.
participantsNUMBER
SECONDARYAdvanced Adenoma Detection/Cecal Intubation RatesAfter 20 months of running study in clinicWe only collected data on polyp detection for the first half of our Fast-tracked participants and all Controls seen over the same time period (4897 in total).Number of Polyps Detected per patientMEAN
SECONDARYLength of WorkdayAfter 12 months of running study in clinic
These 1672 patients are a subset of all patients who were enrolled in this study. We dropped data on a first wave of participants (69 Fast-tracked and 3294 Controls) because of problems incorporating recruitment strategy into clinic. However, data from these individuals was used to build predictive model.
hoursMEAN
SECONDARYCost ComparisonsAfter 12 months of running study in clinic
These 1672 patients are a subset of all patients who were enrolled in this study. We dropped data on a first wave of participants (69 Fast-tracked and 3294 Controls) because of problems incorporating recruitment strategy into clinic. However, data from these individuals was used to build predictive model.
dollarsMEAN

Results by group12

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Percentage of GI Clinic Capacity FilledFast-tracked99.6Standard Deviation 19.4percentage of clinic capacity filled
Percentage of GI Clinic Capacity FilledControl86.4Standard Deviation 21.6percentage of clinic capacity filled
Scheduling-to-procedure Lag TimeFast-tracked8.3Standard Deviation 24.3days
Scheduling-to-procedure Lag TimeControl10.8Standard Deviation 24.0days
Daily Service Denials (Bumps)Fast-tracked0participants
Daily Service Denials (Bumps)Control29participants
Advanced Adenoma Detection/Cecal Intubation RatesFast-tracked2.35Standard Deviation 1.58Number of Polyps Detected per patient
Advanced Adenoma Detection/Cecal Intubation RatesControl2.88Standard Deviation 2.56Number of Polyps Detected per patient
Length of WorkdayFast-tracked8.31Standard Deviation 1.32hours
Length of WorkdayControl7.84Standard Deviation 1.32hours

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDFast-tracked180
Overall StudySTARTEDControl4,855
Overall StudyCOMPLETEDFast-tracked180
Overall StudyCOMPLETEDControl4,855
Overall StudyNOT COMPLETEDFast-tracked0
Overall StudyNOT COMPLETEDControl0

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityFast-tracked
Total, all-cause mortalityControl
Total, other adverse eventsFast-tracked0180
Total, other adverse eventsControl04,855
Total, serious adverse eventsFast-tracked0180
Total, serious adverse eventsControl04,855

Papers3

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
26671702RESULTPubMed
27377518RESULTPubMed
27623103RESULTPubMed

Grants1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal years
I01HX000878Reducing VA No-Shows: Evaluation of Predictive Overbooking Applied to ColonoscopySPIEGEL, BRENNAN MASON ROSSVA GREATER LOS ANGELES HEALTHCARE SYSTEMVeterans Affairs2013 to 2015

Trial comparisons2

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Fast-tracked vs Control: Daily Service Denials (Bumps)Trial comparisons
Fast-tracked vs Control: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01639443

GET https://conductscience.org/api/trials/v1/NCT01639443/registered